MiniMed Group Inc. (MMED)
MMED trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-04-24, https://www.sec.gov/Archives/edgar/data/2062583/000162828026045915/0001628280-26-045915-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-04-24.
Profile
| Field | Value |
|---|---|
| Ticker | MMED on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2026 |
| SEC CIK | 0002062583 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2026
| Line | Value |
|---|---|
| Revenue | $3.1B |
| Net income | -$333.0M |
| Operating income | -$190.0M |
| Net margin | -10.7% |
| Operating margin | -6.1% |
| Revenue growth | +14.3% |
| Cash | $298.0M |
| Total assets | $4.6B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.7× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-09-08 |
| Cash and burn | $207.0M cash; operating cash flow -$69.3M a quarter. | Report 2026-07-31 |
| Shares outstanding | 281,349,931 (2026-09-03). | Cover page 2026-09-03 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers LLP, Minneapolis, Minnesota, United States | PCAOB Form AP 2026-07-28 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q1 2027 2026-07-31 | $843.0M | $0 | -$49.0M | $207.0M | No debt tags | Needs four quarters | 10-Q 2026-09-08 |
| Q4 2026 2026-04-24 | $837.0M | -$185.0M | -$170.0M | $298.0M | No debt tags | $3.1B | 10-K 2026-06-29 |
| Q3 2026 2026-01-23 | $790.0M | -$119.0M | Not filed | $10.0M | No debt tags | Needs four quarters | 10-Q 2026-04-17 |
| Q2 2026 2025-10-24 | Not filed | -$5.0M | Not filed | Not filed | No debt tags | Needs four quarters | 10-Q 2026-04-17 |
| Q1 2026 2025-07-25 | $723.0M | -$19.0M | -$141.0M | $9.0M | No debt tags | Needs four quarters | 10-Q 2026-09-08 |
| Q4 2025 2025-04-25 | $724.0M | -$172.0M | $83.0M | $11.0M | No debt tags | $2.7B | 10-K 2026-06-29 |
| Q3 2025 2025-01-24 | $687.0M | -$10.0M | Not filed | $10.0M | No debt tags | Needs four quarters | 10-Q 2026-04-17 |
| Q2 2025 2024-10-25 | Not filed | -$5.0M | Not filed | Not filed | No debt tags | Needs four quarters | 10-Q 2026-04-17 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-10-05 |
| Latest annual report | 10-K | 2026-06-29 |
| Latest quarterly / interim | 10-Q | 2026-09-08 |
| Latest current report FORM 8-K | 8-K | 2026-11-16 |
| Latest proxy | DEFA14A | 2026-08-21 |
Source: SEC EDGAR submissions feed, 110 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +7.7% |
| 1 month | -2.2% |
| 3 months | -10.1% |
| Year to date | Not enough price history |
| 1 year | Not enough price history |
| From 52-week high | -24.5% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MMSI | Merit Medical Systems Inc. | $86.35 | -0.32% | $5.2B |
| HAE | Haemonetics Corporation | $121.34 | -1.30% | $5.5B |
| ICUI | ICU Medical Inc. | $181.87 | +1.45% | $4.5B |
| TFX | Teleflex Incorporated | $157.10 | +1.51% | $6.2B |
| STVN | Stevanato Group S.p.A. | $15.53 | -1.71% | $4.2B |
| HTFL | Heartflow Inc. | $46.86 | -3.30% | $4.1B |
| NVST | Envista Holdings Corporation | $24.03 | -1.88% | $3.9B |
| PLSE | Pulse Biosciences Inc Common Stock (DE) | $46.36 | -8.09% | $3.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier